出院诊断：1.肝功能异常原因待查，（1） IgG4相关性疾病？（2）自身免疫性肝病？（3）自身免疫性胆管炎？2.肺肿瘤？ 反复肝功能异常为哪般？

The study, published in the New England Journal of Medicine, found that treatment with inebilizumab greatly reduced the symptoms of immunoglobulin G4–related disease (IgG4-RD), compared to placebo.

WASHINGTON — The B-cell depleting agent inebilizumab (Uplizna) dramatically reduced the risk of flares and increased year-long remission of IgG4-related disease (RD), new research has found.

14-19, 2024. New data showcase reduction in disease activity by UPLIZNA® (inebilizumab-cdon) in Immunoglobulin G4-Related Disease (IgG4-RD) and support shorter infusion times for KRYSTEXXA ...